LBT Innovations Advances Pharmaceutical Strategy of Plate System
LBT Innovations (ASX:LBT) advanced its strategy to market and sell its automatic plate assessment system to the pharmaceutical industry, according to a Thursday filing with the Australian bourse.
The medical technology firm is set to conduct an evaluation of its instruments with two pharmaceutical firms by the third quarter of the year, the filing added.